Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush

Area of Science:

• Endocrinology
• Pharmacology
• Metabolic Disorders

Background:

• The chlorpropamide-alcohol flush (CPAF) phenomenon is observed in some diabetic patients.
• Its relationship with drug metabolism and blood levels requires further elucidation.

Purpose of the Study:

• To quantitatively assess the relationship between the CPAF phenomenon, blood acetaldehyde, and chlorpropamide levels in Type II diabetics.
• To investigate the role of chlorpropamide dosage in modulating the CPAF reaction.

Main Methods:

• Quantitative analysis of CPAF phenomenon using skin temperature recordings.
• Measurement of plasma ethanol, acetaldehyde, and chlorpropamide concentrations via gas and high-pressure liquid chromatography.
• Study involved 105 Type II diabetic patients (74 new users, 31 chronic users).

Main Results:

• Significant positive correlations found between plasma acetaldehyde and skin temperature increase.
• Significant positive correlations observed between plasma chlorpropamide and plasma acetaldehyde.
• Significant positive correlations noted between plasma chlorpropamide and skin temperature increase.
• CPAF status (positive/negative) was reversible with changes in chlorpropamide dosage.

Conclusions:

• The CPAF reaction results from chlorpropamide inhibiting the oxidation of acetaldehyde generated from ethanol.
• Plasma chlorpropamide concentration is a critical factor in the CPAF phenomenon.
• The prognostic value of the CPAF test remains undetermined.